B.Sc/B. Pharma 6 Months+ of experience. Minimum Experience/Training Required Candidate with prior/current experience... in same therapy. Candidate from MNC and top Indian Pharma companies will have added advantage. Fluent and confident in...
Job Description We are seeking a skilled and motivated Research and Development Officer to join our team in the pharmaceutical industry. The successful candidate will be responsible for leading research and development activities related ...
name in the healthcare industry and rank as one of the top 10 Pharma Companies in the Indian Pharma Market (IPM... to become the top 5 companies in the Indian Pharma Market. Benefits Offered At Dr. Reddy's we actively help to catalyse...
preferred) with 5-8 years of overall experience in analytics/data consulting, with a focus on Pharma/Healthcare engagements... You should have strong background in Pharma data management, data contracts, process improvement, and data analysis. You should have knowledge of the...
Slone Infosystems IPO allotment finalisation today. Check status on Kfin Technologies Ltd portal. Refund process for non-allotted individuals starts on May 9. Listing date set for May 10. Slone Infosystems IPO GMP at +70. Predicted listing price at ₹149 per share, 88.61% more than IPO price. Continue Reading »
Q4 results today: Bharat Forge, Piramal Enterprises, Kirloskar Oil Engines, Sula Vineyards, Bajaj Consumer Care, Kalpataru Projects International, Greaves Cotton and Sterlite Technologies, are among the other companies that will announce their Q4 earnings today. Continue Reading »
Amkay Products shares made a strong debut on the BSE on Wednesday, May 8, as the stock opened at a premium of 90 per cent at ₹104.50 against its issue price of ₹55 per share. Continue Reading »
Top Stock Recommendations: Sagar Doshi of Nuvama Professional Clients Group recommends these three stocks today - ITC Ltd, Tata Consultancy Services Ltd (TCS), and Mahindra & Mahindra Financial Services Ltd. Continue Reading »
PB Fintech's shares fluctuated, hitting a low of ₹1159 before recovering to ₹1279.80, a 10.50% increase. Q4FY24 results showed a net profit of ₹60.19 crore and revenue of ₹1,089.57 crore. For the full fiscal year, net profit rose to ₹64 crore and revenue to ₹3,438 crore. Continue Reading »
One a penny stock, Marsons has given multifold returns to its investors this year so far as well as in the last one year. The stock has skyrocketed around 602 percent in 2024 YTD from ₹7.75 in December 2023 to currently trade at its 52-week high 54.38. Continue Reading »